Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2024

Open Access 09-03-2024 | Adverse Effects of Cancer Therapy | Case report

Profound postinduction hypotension precipitated by immune checkpoint inhibitors: a case report

Authors: Lu Che, Afang Zhu, Wen Chen, Chunhua Yu

Published in: Journal of Medical Case Reports | Issue 1/2024

Login to get access

Abstract

Background

With the increasing use of immune checkpoint inhibitors (ICIs) in cancer therapy, perioperative healthcare professionals need to be vigilant about potential immune-related adverse events (irAEs). We report a case of severe postinduction hypotension in a patient undergoing laparotomy due to suspected intraabdominal bleeding from gastric cancer and Krukenberg tumors, caused by unrecognized hypothyroidism precipitated by ICIs.

Case presentation

A 65-year-old Chinese female with a history of gastric adenocarcinoma and Krukenberg tumors, previously treated with nivolumab, presented to the emergency room with abdominal pain and hypotension. Despite ruling out other causes, including hypovolemia and anaphylaxis, her hypotension persisted. The patient was found to have severe hypothyroidism, likely an irAE from the use of nivolumab. Thyroxine replacement therapy resolved the hypotension, and the patient recovered uneventfully after surgery.

Conclusions

This case underscores the importance of considering irAEs, such as hypothyroidism, in patients treated with ICIs. Perioperative healthcare providers must remain vigilant for potential complications and promptly recognize and manage irAEs to optimize patient outcomes.
Literature
4.
go back to reference Murkin JM. Anesthesia and hypothyroidism: a review of thyroxine physiology, pharmacology, and anesthetic implications. Anesth Analg. 1982;61(4):371–83.CrossRefPubMed Murkin JM. Anesthesia and hypothyroidism: a review of thyroxine physiology, pharmacology, and anesthetic implications. Anesth Analg. 1982;61(4):371–83.CrossRefPubMed
8.
go back to reference Bogojevic M, Bansal V, Pattan V, Singh R, Tekin A, Sharma M, et al. Association of hypothyroidism with outcomes in hospitalized adults with COVID-19: results from the International SCCM Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry. Clin Endocrinol (Oxf). 2022. https://doi.org/10.1111/cen.14699.CrossRefPubMed Bogojevic M, Bansal V, Pattan V, Singh R, Tekin A, Sharma M, et al. Association of hypothyroidism with outcomes in hospitalized adults with COVID-19: results from the International SCCM Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry. Clin Endocrinol (Oxf). 2022. https://​doi.​org/​10.​1111/​cen.​14699.CrossRefPubMed
9.
go back to reference Kim JM, Hackman L. Anesthesia for untreated hypothyroidism: report of three cases. Anesth Analg. 1977;56(2):299–302.CrossRefPubMed Kim JM, Hackman L. Anesthesia for untreated hypothyroidism: report of three cases. Anesth Analg. 1977;56(2):299–302.CrossRefPubMed
11.
go back to reference Weinberg AD, Brennan MD, Gorman CA, Marsh HM, O’Fallon WM. Outcome of anesthesia and surgery in hypothyroid patients. Arch Intern Med. 1983;143(5):893–7.CrossRefPubMed Weinberg AD, Brennan MD, Gorman CA, Marsh HM, O’Fallon WM. Outcome of anesthesia and surgery in hypothyroid patients. Arch Intern Med. 1983;143(5):893–7.CrossRefPubMed
Metadata
Title
Profound postinduction hypotension precipitated by immune checkpoint inhibitors: a case report
Authors
Lu Che
Afang Zhu
Wen Chen
Chunhua Yu
Publication date
09-03-2024
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2024
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-024-04375-9

Other articles of this Issue 1/2024

Journal of Medical Case Reports 1/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine